-
RNAseq on 20 samples of multiple myeloma patients and 3 normal plasma cells.
Study
EGAS00001004347
-
Cell-free DNA fragmentation patterns and personalized sequencing reveal circulating tumor DNA in urine and plasma of glioma patients
Study
EGAS00001004355
-
Detection of clinically relevant genetic and transcriptomic landscape in DLBCL uniformly treated by R-CHOP
Study
EGAS00001002657
-
RNAseq of Colorectal cancer organoid-stroma biobank cohort
Study
EGAS00001007300
-
Single-cell RNA-sequencing reveals that glioblastoma recapitulates a normal neurodevetlopmental hierarchy
Study
EGAS00001004422
-
Spatial tumor microenvironment characterization and outcome of relapsed/refractory classic Hodgkin lymphoma
Study
EGAS00001007261
-
Proteomic Analysis of Non-Muscle Invasive and Muscle Invasive Bladder Cancer Highlights Distinct Subgroups With Metabolic, Matrisomal, and Immune Hallmarks
Study
EGAS00001007290
-
Spatio-temporal evolution of the primary glioblastoma genome (newly added after 2015)
Study
EGAS00001001800
-
Clinical efficacy and biomarker analysis of neoadjuvant atezolizumab in operable urothelial carcinoma in the ABACUS trial
Study
EGAS00001004445
-
Mutational_burden_in_human_hair_follicles
Study
EGAS00001004462
-
Genetic Risk for Subsequent Neoplasms among Long-term Survivors of Childhood Cancer in the St. Jude Lifetime Cohort
Study
EGAS00001002499
-
Cabozantinib Response in ETV6-NTRK3 G623R Positive Carcinoma HIPO-021
Study
EGAS00001004494
-
Sclerosing Epithelioid Fibrosarcoma sequencing data
Study
EGAS00001007370
-
Methylation-based classification of human mesenchymal chondrosarcoma
Study
EGAS00001007042
-
Pre-existing immunity drives the response to neoadjuvant chemotherapy in esophageal adenocarcinoma
Study
EGAS00001007245
-
Exploration of neuroblastoma xenograft models for tumor extracellular RNA profiling in murine blood plasma
Study
EGAS00001007295
-
Survival Benefit and Genetic Profile of Pemetrexed as Initial Chemotherapy in Selected Chinese Patients with Advanced Lung Adenocarcinoma
Study
EGAS00001004546
-
Therapeutic vulnerabilities in the DNA damage response for the treatment of ATRX mutant neuroblastoma
Study
EGAS00001004550
-
Novel mutations in TOP2A in gliomas
Study
EGAS00001004556
-
Exome and transcriptome sequencing of Desmoplastic Small Round Cell Sarcoma
Study
EGAS00001004575
-
RNA sequencing of chondrosarcoma
Study
EGAS00001004585
-
Clinical Activity of Combined Telomerase Vaccination and Pembrolizumab in Advanced Melanoma: Results from a Phase I Trial
Study
EGAS00001007210
-
Whole genome sequencing of patients with or at risk for HCC
Study
EGAS00001007249
-
The immunological characterization of expanded tumor-infiltrating lymphocytes in renal cell carcinoma patients
Study
EGAS00001006952
-
A novel TP53-KPNA3 translocation defines a de novo treatment-resistant clone in osteosarcoma
Study
EGAS00001001805
-
ICGC Oesophageal adenocarcinoma - tumour samples
Study
EGAS00001000725
-
Ovarian carcinosarcoma genomics and eribulin response
Study
EGAS00001006555
-
Molecular and functional profiling of plasmablastic lymphoma
Study
EGAS00001004659
-
Clonal selection and double hit events involving tumor suppressor genes underlie relapse from total therapy
Study
EGAS00001001810
-
WGS of 32 paired SRCC samples
Study
EGAS00001002668
-
Multiomics Characterization of Low-grade Serous Ovarian Carcinoma
Study
EGAS00001004724
-
Mutation-specific non-canonical pathway of PTEN as a distinct therapeutic target for glioblastoma
Study
EGAS00001004753
-
Robust detection of translocations in lymphoma FFPE samples using Targeted Locus Capture-based sequencing
Study
EGAS00001004760
-
H3K27ac and RNA-seq data of neuroblastoma PDXs and/or primary tumors
Study
EGAS00001002505
-
Alveolar Rhabdomyosarcoma case report
Study
EGAS00001004828
-
OpACIN-neo – A Multicenter Phase 2 Study to identify the Optimal neo-Adjuvant Combination scheme of Ipilimumab and Nivolumab – RNA sequencing
Study
EGAS00001004833
-
Gut microbiome sequencing in patients receiving combination immune checkpoint blockade
Study
EGAS00001004885
-
Serial TERT rearrangement breakpoint quantification in circulating tumor DNA enables minimal residual disease monitoring in patients with neuroblastoma
Study
EGAS00001007365
-
Therapeutic Targeting of Ependymoma as Informed by Oncogenic Enhancer Profiling
Study
EGAS00001002696
-
Analysis of enhancer-promoter connectivity alterations
Study
EGAS00001007411
-
Genomic evolution and transcriptional changes in the evolution of prostate cancer into neuroendocrine and ductal carcinoma types
Study
EGAS00001007412
-
Single cell and plasma RNA sequencing
Study
EGAS00001005194
-
Clinical outcomes in ctDNA-positive urothelial carcinoma patients treated with adjuvant immunotherapy
Study
EGAS00001004997
-
Genome-wide cell-free DNA biological patterns in patients with cancer
Study
EGAS00001007400
-
Characterization of DLBCL with a PMBL gene expression signature
Study
EGAS00001005057
-
Subtype specific progression from DCIS to invasive breast cancer
Study
EGAS00001001866
-
Multi-omic analysis of the tumor microenvironment shows clinical correlations in Ph1 study of atezolizumab +/- SoC in MM
Study
EGAS00001007286
-
Genomic characterization of hepatocellular carcinoma in Hispanic patients
Study
EGAS00001007431
-
Multi-omics analysis of primary glioblastoma cell-lines shows recapitulation of pivotal molecular features of parental tumors
Study
EGAS00001001871
-
The Genetic Landscape of Ocular Adnexa MALT Lymphoma Reveals Frequent Aberrations in NFAT and MEF2B Signaling Pathways
Study
EGAS00001006631
-
Pediatric Papillary Thyroid Carcinoma RNA-Seq
Study
EGAS00001005182
-
Pediatric Papillary Thyroid Carcinoma Whole Exome Sequencing
Study
EGAS00001005187
-
WES of Colorectal cancer organoid-stroma biobank cohort
Study
EGAS00001007301
-
Prognostic markers of DNA methylation and NGS sequencing in progressive glioblastoma from the EORTC-26101 trial
Study
EGAS00001007421
-
Molecular characterization of Barrett’s esophagus at single cell resolution
Study
EGAS00001005221
-
Esophageal Adenocarcinoma Organoid Genomics
Study
EGAS00001005224
-
Non-Mendalian inheritance of extrachromosal DNA elements can drive disease evolution in glioblastoma
Study
EGAS00001001878
-
EATL-II STUDY
Study
EGAS00001001879
-
Spatiotemporal genomic architecture informs precision oncology in glioblsatoma
Study
EGAS00001001880
-
Single-cell RNA sequencing of 6 follicular lymphoma tumors
Study
EGAS00001005257
-
Translation of non-canonical open reading frames as a cancer cell survival mechanism in childhood medulloblastoma
Study
EGAS00001007426
-
ICGC Oesophageal adenocarcinoma - lymph-node samples
Study
EGAS00001000727
-
Integrative Profiling of T790M Negative EGFR Mutated NSCLC Reveals Pervasive Lineage Transition and Therapeutic Opportunities
Study
EGAS00001005389
-
Alveolar Rhabdomyosarcoma sequencing data
Study
EGAS00001005387
-
Epithelioid haemangioendothelioma (EHE) case series from the Stafford Fox Rare Cancer Program
Study
EGAS00001007474
-
Inactivation of TGFβ receptors in stem cells drives cutaneous squamous cell carcinoma - 30 whole exomes
Study
EGAS00001001892
-
Single-cell profiling of co-cultures of GSCCs and macrophages
Study
EGAS00001007482
-
Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma
Study
EGAS00001007486
-
Embryonal Rhabdomyosarcoma sequencing data
Study
EGAS00001005502
-
WGS_of_healhy_mesothelial_cells_and_primary_mesothelima_cell_lines
Study
EGAS00001005559
-
Integrated genetic and epigenetic analysis of myxofibrosarcoma
Study
EGAS00001002889
-
ExomeSeq Neoantigen Immunogenicity Landscapes
Study
EGAS00001007508
-
RNASeq Neoantigen Immunogenicity Landscape
Study
EGAS00001007509
-
Osteosarcoma sequencing data
Study
EGAS00001005600
-
Comparison of EGF and PDGF driven glioblastomas.
Study
EGAS00001001900
-
Single-cell characterization of anti-LAG3+anti-PD1 treatment in melanoma patients
Study
EGAS00001005580
-
Genomic evolution and transcriptional changes in the evolution of prostate cancer into neuroendocrine and ductal carcinoma types (RNAseq)
Study
EGAS00001007428
-
Effective reprogramming of patient-derived M2-polarized glioblastoma-associated microglia/macrophages by treatment with GW2580
Study
EGAS00001007466
-
Oncoprint GSCCs
Study
EGAS00001007481
-
Myeloid cell programming in patients with non-medullary thyroid carcinoma
Study
EGAS00001005594
-
A MITF germline mutation predisposes to melanoma and renal cell carcinoma
Study
EGAS00000000048
-
Ewing's sarcoma sequencing data
Study
EGAS00001005689
-
Glioma sequencing data
Study
EGAS00001006355
-
Soft tissue sarcoma sequencing data
Study
EGAS00001006356
-
Whole Genome Sequencing of Neuroblastoma
Study
EGAS00001000222
-
Driver mutations in histone H3.3 and chromatin remodelling genes in paediatric glioblastoma
Study
EGAS00001000226
-
Integrated genomic analyses identify ARID1A and ARID1B alterations in the childhood cancer neuroblastoma
Study
EGAS00001000369
-
Recurrent somatic mutations in POLR2A define a distinct subset of meningiomas
Study
EGAS00001001916
-
Integrated genomic analysis identifies recurrent mutations and evolution patterns driving the initiation and progression of follicular lymphoma.
Study
EGAS00001000399
-
Sequencing of an organoid biobank for childhood soft tissue sarcoma.
Study
EGAS00001005912
-
Whole genome sequencing and whole exome sequencing of mucosal melanoma
Study
EGAS00001000474
-
Whole genome sequencing of acral melanomas
Study
EGAS00001000486
-
Overexpression of the miR-17-92 cluster in colorectal adenoma organoids induces a carcinoma-like genotype
Study
EGAS00001005949
-
Whole Exome Sequences from Iberian Roma samples
Study
EGAS00001004599
-
Landscape of somatic mutations and clonal evolution in mantle cell lymphoma
Study
EGAS00001000510
-
Combination of ribociclib and gemcitabine for the treatment of medulloblastoma
Study
EGAS00001006001
-
Whole exome sequencing of peripheral T-cell lymphoma (PTCL)
Study
EGAS00001000557
-
POT1_splice_site_mutant_analysis
Study
EGAS00001000571
-
Whole genome sequencing of metastatic melanomas from a patient with primary resistance to BRAF inhibition
Study
EGAS00001000580
-
Whole genome sequencing of tumour and normal paired samples of diffuse intrinsic pontine gliomas
Study
EGAS00001000572